96,29 €
inkl. MwSt.
Sofort per Download lieferbar
  • Format: PDF

This is the first edited collection on veterinary applications of electroporation. Written by an international team of experts, this book presents worldwide emerging therapy options for cancer treatments in veterinary oncology practice.
Electroporation offers a precision tool to target cancer cells without destroying surrounding tissue structures. The opening of tumor cell membranes facilitates local control of solid tumors either through the delivery of chemotherapeutics or by direct ablation of tissues using electric fields. In addition, transfer of gene-based products into the cancer…mehr

Produktbeschreibung
This is the first edited collection on veterinary applications of electroporation. Written by an international team of experts, this book presents worldwide emerging therapy options for cancer treatments in veterinary oncology practice.

Electroporation offers a precision tool to target cancer cells without destroying surrounding tissue structures. The opening of tumor cell membranes facilitates local control of solid tumors either through the delivery of chemotherapeutics or by direct ablation of tissues using electric fields. In addition, transfer of gene-based products into the cancer cells can be used for genetic vaccination to achieve systemic responses and cancer control.

Readers will discover valuable reference texts for practitioner education, including chapters on electrodes for unique anatomical access and treatment planning for deep-seated tumors, different immunotherapy applications with gene electrotransfer, calcium electroporation, irreversible electroporation applications and combinations with other common treatments such as surgery, radiation therapy and chemotherapy.

Therapy options with electroporation are gaining interest around the world in both human and veterinary oncology, making this book valuable for oncologists, surgeons, primary care veterinarians, residents, interns and students at veterinary schools, where teaching of Electrochemotherapy will become part of the curriculum. Featuring cross-disciplinary authorship, this work further contributes to advances in comparative medicine and translation research in support of the One Health concept.

Autorenporträt
Dr. Joseph A. Impellizeri DVM, DACVIM (Oncology), MRCVS is the Chief Medical Officer of Veterinary Oncology Services, PLLC, New York, USA. after graduating from the College of Veterinary Medicine at Cornell University, Dr. Impellizeri completed a small animal medical and surgical internship at the College of Veterinary Medicine and Biological Sciences at Colorado State University. After 5 years in private practice and emergency critical care, he completed his Oncology Residency and became a Diplomate of the American College of Veterinary Internal Medicine, Sub-Specialty of Oncology. An advocate of advancing cancer treatments in pets and people, Dr. Impellizeri holds an academic position as a Visiting Scholar in the Department of Biology at Vassar College in Poughkeepsie, NY. And is a member of the Royal college of veterinary surgeons. Dr. Impellizeri created the Barrymore Center for Advanced Cancer Care specializing in U.S. based Electrogenetherapy/Electrochemotherapy comprising cancer immunotherapy and localized targeted therapies to battle cancer in pets. Dr. Impellizeri is a frequent lecturer across the globe and continues to provide consults and treatments throughout the United States.